United Therapeutics buy Wells Fargo & Company
Start price
08.12.23
/
50%
€224.60
Target price
08.12.24
€287.40
Performance (%)
42.30%
Price
04.10.24
€324.20
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan for United Therapeutics has seen massive gains of 42.30%. This prediction currently runs until 08.12.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
United Therapeutics | 0.903% | 0.903% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Wells_Fargo___Compan for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Co. (NASDAQ: UTHR) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $309.00 price target on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€314.10
20.08.24
20.08.24
€341.89
20.08.25
20.08.25
3.22%
04.10.24
04.10.24
United Therapeutics
Start price
Target price
Perf. (%)
€255.70
12.06.24
12.06.24
€323.16
12.06.25
12.06.25
26.79%
04.10.24
04.10.24
United Therapeutics
Start price
Target price
Perf. (%)
€220.00
07.03.24
07.03.24
€298.84
07.03.25
07.03.25
47.36%
04.10.24
04.10.24